Wesley Johnson - Jul 17, 2024 Form 4 Insider Report for ANGIODYNAMICS INC (ANGO)

Role
Director
Signature
/s/ Stephen A. Trowbridge, Attorney in Fact
Stock symbol
ANGO
Transactions as of
Jul 17, 2024
Transactions value $
$0
Form type
4
Date filed
7/19/2024, 05:18 PM
Previous filing
Jul 21, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANGO Common Stock Award $0 +20.5K +19.5% $0.00 126K Jul 17, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The acquisition of 20,541 shares of common stock of AngioDynamics, Inc.("AngioDynamics") represents 20,541 restricted stock units granted as regular annual compensation for service as a director of AngioDynamics. The restricted stock units immediately vested at the time of grant.